Cargando…

Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy: A meta-analysis

OBJECTIVES: To evaluate the effect of pegylated interferon maintenance therapy in patients with chronic hepatitis C who failed initial antiviral therapy. METHODS: This is a meta-analysis of 6 randomized controlled trials that met the eligibility criteria. In all, 2438 chronic hepatitis C patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Hung-Chang, Liao, Hsien-Hua, Chen, Shiuan-Chih, Tsao, Shih-Ming, Lee, Yuan-Ti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531240/ https://www.ncbi.nlm.nih.gov/pubmed/31083223 http://dx.doi.org/10.1097/MD.0000000000015563

Ejemplares similares

Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis
por: Li, Chien-Feng, et al.
Publicado: (2020)

Human papillomavirus prevalence and behavioral risk factors among HIV-infected and HIV-uninfected men who have sex with men in Taiwan
por: Lin, Chia-Chun, et al.
Publicado: (2018)

Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection
por: Liu, Chen-Hua, et al.
Publicado: (2017)

Pulmonary Mucormycosis in a Patient with Systemic Lupus Erythematosus: A Diagnostic and Treatment Challenge
por: Hung, Hung-Chang, et al.
Publicado: (2015)

Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance
por: Zeng, Zhutian, et al.
Publicado: (2016)

Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
por: Chung, Sung Won, et al.
Publicado: (2018)

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents
por: Huang, Chao-Min, et al.
Publicado: (2017)

Peginterferon Alfa-2a plus Ribavirin in Japanese Patients Infected with Hepatitis C Virus Genotype 2 Who Failed Previous Interferon Therapy
por: Kanda, Tatsuo, et al.
Publicado: (2012)

Prevalence of thyroid disorders in hepatitis C virus positive patients on interferon and antiviral therapy
por: Goyal, Gitanjali, et al.
Publicado: (2016)

Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy
por: Urbanowicz, Arkadiusz, et al.
Publicado: (2018)

Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts
por: Lin, Kung-Hung, et al.
Publicado: (2012)

Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks
por: Manns, M P, et al.
Publicado: (2012)

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
por: Kamal, Sanaa M
Publicado: (2014)

Salvage Therapy in Cancer Patients With Hepatitis C Infection Failing Direct-Acting Antivirals: A Prospective Study
por: Pritchard, Haley, et al.
Publicado: (2017)

The interferon system as a basis for antiviral therapy or prophylaxis
por: Billiau, A.
Publicado: (1985)

The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs
por: Ti, Lianping, et al.
Publicado: (2018)

Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018)

A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma
por: Rohatiner, A, et al.
Publicado: (2001)

Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
por: Kozielewicz, Dorota, et al.
Publicado: (2015)

Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir
por: Katiyar, Harshita, et al.
Publicado: (2023)

Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
por: Lin, Chih-Lang, et al.
Publicado: (2023)

What to do if standard therapy for hepatitis C fails
por: Tanwar, Sudeep, et al.
Publicado: (2009)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

The Role of Interferon in Hepatitis B Therapy
por: Rijckborst, Vincent, et al.
Publicado: (2010)

Prevalence and Incidence of Depression during Interferon-Based Antiviral Therapy in Chronic Hepatitis C Patients in the Republic of Korea
por: Baeg, Joo Yeong, et al.
Publicado: (2017)

2943. Hazardous Alcohol Use and Direct-acting Antiviral Therapy Initiation Among People Who Inject Drugs with Current Hepatitis C Infection
por: Karimi-Sari, Hamidreza, et al.
Publicado: (2023)

Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
por: Izumi, Namiki, et al.
Publicado: (2018)

Rhabdomyolysis Following Initiation of Antiviral Therapy with Oseltamivir
por: Puttagunta, Harika, et al.
Publicado: (2018)

Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
por: Chen, Chun-Hsien, et al.
Publicado: (2023)

High frequency of antiviral drug resistance and non-b subtypes in HIV-1 patients failing antiviral therapy in Cuba
por: Kouri, Vivian, et al.
Publicado: (2014)

Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy
por: Chen, Yen-Chun, et al.
Publicado: (2021)

Optimal timing of antiviral therapy for patients with malignant tumor who presented with hepatitis B reactivation during chemotherapy and/or immunosuppressive therapy
por: Zou, Xiaofang, et al.
Publicado: (2020)

Successful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals
por: Nagao, Yumiko, et al.
Publicado: (2016)

Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
por: Liu, Chen-Hua, et al.
Publicado: (2018)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity
por: Liao, Yuan, et al.
Publicado: (2019)

An evolution in switching therapy for psoriasis patients who fail to meet treatment goals
por: Kerdel, Francisco, et al.
Publicado: (2015)

Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed
por: Yoshida, Kanako, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e73hig18mdvogtb8r40c5knt6r